Effect of Laser Photocoagulation and Intravitreal Bevacizumab Injection on Zone I Retinopathy of Prematurity
Journal of the Korean Ophthalmological Society
;
: 120-126, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-161771
ABSTRACT
PURPOSE:
To evaluate the efficacy and safety of laser photocoagulation and intravitreal injection of bevacizumab in zone I ROP (retinopathy of prematurity) accompanied with plus signs.METHODS:
We performed a retrospective analysis of the records of 12 eyes of 7 premature infants with zone I ROP accompanied with plus signs, treated with diode laser photocoagulation and intravitreal injection of bevacizumab that were followed-up for at least 12 months.RESULTS:
Mean gestational age was 30 + 2 weeks, mean birth weight was 1437 +/- 478 g, mean follow-up period was 14.7 +/- 2.0 months and mean age of diagnosis was 36 + 3 weeks. Plus signs were disappeared after an average of 10.1 +/- 2.4 postoperative days in all 12 eyes. The outcome was favorable in 11 (91.7%) of 12 treated eyes after a minimum of 12 months of follow-up. No local or systemic complications were observed.CONCLUSIONS:
Laser photocoagulation and intravitreal injection of bevacizumab are effective and safe for treatment of zone I ROP accompanied with plus signs and require long-term follow-up.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Peso al Nacer
/
Retinopatía de la Prematuridad
/
Recien Nacido Prematuro
/
Estudios Retrospectivos
/
Estudios de Seguimiento
/
Edad Gestacional
/
Diterpenos
/
Ojo
/
Láseres de Semiconductores
/
Inyecciones Intravítreas
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
/
Recién Nacido
Idioma:
Coreano
Revista:
Journal of the Korean Ophthalmological Society
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS